Excercise induced rise in Severity of Altitude Illness
运动导致高原病严重程度上升
基本信息
- 批准号:6827577
- 负责人:
- 金额:$ 45.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-10 至 2005-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Applicant's abstract): Many hundreds of studies of acute mountain
sickness (AMS) over the past two centuries have examined the role of
ventilation, pulmonary gas exchange and fluid balance, yet the pathophysiology
of AMS remains largely unsolved. AMS incurs significant medical risks and costs
since as many as 5 percent of cases can develop life-threatening high altitude
cerebral edema (HACE). AMS itself is a substantial public health problem with a
prevalence of 15-65 percent in visitors to high altitude. This proposal focuses
on the role of brain swelling, which can include elevated brain water and blood
volume, in the pathophysiology of AMS. This proposal uses exercise as a tool to
develop more severe symptoms of AMS sooner than would be the case in resting
subjects. Our approach departs from the traditional paradigm, followed by many
of us in this field, of searching for clues to the pathophysiology of AMS in
the observed peripheral responses (pulmonary, renal, vascular). Our rationale
for focusing on brain swelling is that a) the symptoms of AMS are largely
neurological; b) HACE, considered the end-stage of severe AMS, has recently
been identified as a vasogenic edema, opening the door for a role for
blood-brain barrier (BBB) permeability in AMS; c) new, noninvasive techniques
make measurement of brain water and blood volume possible; and d) available
experimental evidence and theoretical arguments support a significant role for
brain swelling in the pathophysiology of AMS. We recently showed that exercise
caused a more than 3 fold rise in AMS symptom severity, a drop in arterial
oxygen saturation (SaO2) during exercise, and slight fluid retention. We also
recently showed that subjects ill with AMS had a small drop in plasma volume
and a large rise in extracellular water compared to those that remained free of
AMS. In further studies, magnetic resonance imaging revealed that most brains
swell when humans ascend to high altitude. Our overall hypothesis is that brain
swelling causes the symptoms of AMS. Our approach is to apply several new and
innovative technologies to solving the pathophysiology of AMS. These include
noninvasive techniques to measure and manipulate cerebral blood volume,
intracranial pressure, BBB opening, cerebrospinal volumes and selected
cellular, molecular and genetic responses to hypoxia in people developing AMS.
Our three specific aims are 1) to determine the role of elevated brain water in
brain swelling and AMS; 2) to determine the role of BBB permeability in AMS;
and 3) to determine the role of select cellular, molecular and genetic factors
in AMS. The results from the proposed studies will increase our understanding
of the role of the brain, brain water and brain swelling in other conditions,
both those associated with oxygen depravation, and those where the primary
insult is to the brain.
描述(申请人摘要):数百项急性山地研究
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT C ROACH其他文献
ROBERT C ROACH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT C ROACH', 18)}}的其他基金
Excercise induced rise in Severity of Altitude Illness
运动导致高原病严重程度上升
- 批准号:
6528406 - 财政年份:2001
- 资助金额:
$ 45.47万 - 项目类别:
Excercise induced rise in Severity of Altitude Illness
运动导致高原病严重程度上升
- 批准号:
6780834 - 财政年份:2001
- 资助金额:
$ 45.47万 - 项目类别:
Excercise induced rise in Severity of Altitude Illness
运动导致高原病严重程度上升
- 批准号:
6485707 - 财政年份:2001
- 资助金额:
$ 45.47万 - 项目类别:
Excercise induced rise in Severity of Altitude Illness
运动导致高原病严重程度上升
- 批准号:
6603945 - 财政年份:2001
- 资助金额:
$ 45.47万 - 项目类别:
相似海外基金
ICF: Enhancing Blood-Brain Barrier Opening with Ultrasound and Microwaves for Targeted Drug Delivery
ICF:利用超声波和微波增强血脑屏障开放以实现靶向药物输送
- 批准号:
MR/Z503848/1 - 财政年份:2024
- 资助金额:
$ 45.47万 - 项目类别:
Research Grant
Development of blood-brain barrier-penetrating oligosaccharides
穿透血脑屏障寡糖的开发
- 批准号:
23K11852 - 财政年份:2023
- 资助金额:
$ 45.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Venom-derived blood-brain-barrier shuttles
毒液衍生的血脑屏障穿梭机
- 批准号:
DP230102707 - 财政年份:2023
- 资助金额:
$ 45.47万 - 项目类别:
Discovery Projects
Defining mechanisms of blood-brain barrier dysfunction in cerebral small vessel disease using advanced 3D in vitro models.
使用先进的 3D 体外模型定义脑小血管疾病血脑屏障功能障碍的机制。
- 批准号:
MR/W027119/1 - 财政年份:2023
- 资助金额:
$ 45.47万 - 项目类别:
Fellowship
Understanding suppression of transcytosis in formation of the blood-brain barrier (BBB) and how Calcrl/Ramp2 signalling limits BBB permeability
了解血脑屏障 (BBB) 形成过程中转胞吞作用的抑制以及 Calcrl/Ramp2 信号如何限制 BBB 通透性
- 批准号:
MR/X008215/1 - 财政年份:2023
- 资助金额:
$ 45.47万 - 项目类别:
Research Grant
Bisphenol-Induced Blood-Brain Barrier Dysfunction in Alzheimer’s Disease
双酚引起的阿尔茨海默氏病血脑屏障功能障碍
- 批准号:
10713025 - 财政年份:2023
- 资助金额:
$ 45.47万 - 项目类别:
The blood-brain barrier and Alzheimer pathology
血脑屏障和阿尔茨海默病病理学
- 批准号:
10800246 - 财政年份:2023
- 资助金额:
$ 45.47万 - 项目类别:
Circadian Rhythms in Blood Brain Barrier Permeability and Increased Efficacy of Chemotherapy for Brain Metastases
血脑屏障通透性的昼夜节律和脑转移化疗疗效的提高
- 批准号:
10663717 - 财政年份:2023
- 资助金额:
$ 45.47万 - 项目类别:
Blood brain barrier integrity and immune dynamics contributing to neuropsychiatric sequela in COVID long-haulers
血脑屏障完整性和免疫动态导致新冠长途运输者的神经精神后遗症
- 批准号:
10688300 - 财政年份:2023
- 资助金额:
$ 45.47万 - 项目类别:
MicroRNAs, Mitochondria and the Blood-Brain Barrier - Therapeutic Targets for Stroke
MicroRNA、线粒体和血脑屏障——中风的治疗靶点
- 批准号:
10587899 - 财政年份:2023
- 资助金额:
$ 45.47万 - 项目类别: